3rdPartyFeeds

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of NFLX, ABMD and MDP

NEW YORK, NY / ACCESSWIRE / September 17, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Read More...

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="NEW YORK, NY / ACCESSWIRE / September 17, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.” data-reactid=”11″>NEW YORK, NY / ACCESSWIRE / September 17, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Netflix, Inc. (NFLX)” data-reactid=”12″>Netflix, Inc. (NFLX)

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Investors Affected : April 17, 2019 – July 17, 2019” data-reactid=”13″>Investors Affected : April 17, 2019 – July 17, 2019

A class action has commenced on behalf of certain shareholders in Netflix, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Netflix would not be able to gain its expected target number of new subscribers in the second quarter of 2019; (2) Netflix would also lose subscribers from the United States in the second quarter of 2019; and (3) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Shareholders may find more information at https://securitiesclasslaw.com/securities/netflix-inc-loss-submission-form/?id=3555&amp;from=1” data-reactid=”15″>Shareholders may find more information at https://securitiesclasslaw.com/securities/netflix-inc-loss-submission-form/?id=3555&from=1

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Abiomed, Inc. (ABMD)” data-reactid=”16″>Abiomed, Inc. (ABMD)

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Investors Affected : January 31, 2019 – July 31, 2019” data-reactid=”17″>Investors Affected : January 31, 2019 – July 31, 2019

A class action has commenced on behalf of certain shareholders in Abiomed, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Abiomed’s revenue growth was in decline; (ii) the Company did not have a sufficient plan in place to stem its declining revenue growth; (iii) the Company was unlikely to restore its revenue growth over the next several fiscal quarters; (iv) consequently, Abiomed was reasonably likely to revise its full-year 2020 guidance in a way that would fall short of the Company’s prior projections and market expectations; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Shareholders may find more information at https://securitiesclasslaw.com/securities/abiomed-inc-loss-submission-form/?id=3555&amp;from=1” data-reactid=”19″>Shareholders may find more information at https://securitiesclasslaw.com/securities/abiomed-inc-loss-submission-form/?id=3555&from=1

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Meredith Corporation (MDP)” data-reactid=”20″>Meredith Corporation (MDP)

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Investors Affected : January 31, 2018 – September 5, 2019” data-reactid=”21″>Investors Affected : January 31, 2018 – September 5, 2019

A class action has commenced on behalf of certain shareholders in Meredith Corporation. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Time, Inc. acquisition was not as profitable as the Company had claimed; (2) the Company would incur additional costs for strategic investments to improve the Time business; (3) as a result, the Company’s earnings would be materially and adversely impacted; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Shareholders may find more information at https://securitiesclasslaw.com/securities/meredith-corporation-loss-submission-form/?id=3555&amp;from=1” data-reactid=”23″>Shareholders may find more information at https://securitiesclasslaw.com/securities/meredith-corporation-loss-submission-form/?id=3555&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (212) 537-9430
Fax: (833) 862-7770″ data-reactid=”25″>CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (212) 537-9430
Fax: (833) 862-7770

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="SOURCE: The Gross Law Firm” data-reactid=”26″>SOURCE: The Gross Law Firm

View source version on accesswire.com:
https://www.accesswire.com/560046/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-NFLX-ABMD-and-MDP

Read More

Add Comment

Click here to post a comment